Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 17.14M | $ 4.45M | $ 12.69M |
3/31/2025 | $ 15.92M | $ 3.87M | $ 12.05M |
12/31/2024 | $ 15.04M | $ 4.41M | $ 10.63M |
9/30/2024 | $ 13.89M | $ 4.47M | $ 9.42M |
6/30/2024 | $ 10.79M | $ 4.56M | $ 6.24M |
3/31/2024 | $ 11.35M | $ 4.18M | $ 7.16M |
12/31/2023 | $ 11.47M | $ 4.2M | $ 7.27M |
9/30/2023 | $ 11.96M | $ 3.33M | $ 8.63M |
6/30/2023 | $ 10.95M | $ 4.19M | $ 6.75M |
3/31/2023 | $ 12.25M | $ 3.84M | $ 8.41M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for IMMUCELL CORP is calculated as follows: AssetsC [ $ 9.94M ] - LiabilitesC [ $ 1.8M ]
(=) Working Capital [ $ 8.14M ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |